(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Smiths Medical 21-4054-24 - KIT PORT-A-CATH SINGLE LUMEN 1.6MM ID 2.6MM OD POLYSULFONE/TITANIUM PORT 7.8FR 76CM POLYURETHANE CATHETER STRAIGHT/BLUNT NEEDLE UNASSEMBLED

KIT PORT-A-CATH SINGLE LUMEN 1.6MM ID 2.6MM OD POLYSULFONE/TITANIUM PORT 7.8FR 76CM POLYURETHANE CATHETER STRAIGHT/BLUNT NEEDLE UNASSEMBLED
Part Number Smiths Medical 21-4054-24
SKU Number CIA1074150
Sell Unit EACH
Ships Within Special Order
List Price $404.09
Enter a valid quantity
Product Description

Smiths Medical 21-4054-24 - KIT PORT-A-CATH SINGLE LUMEN 1.6MM ID 2.6MM OD POLYSULFONE/TITANIUM PORT 7.8FR 76CM POLYURETHANE CATHETER STRAIGHT/BLUNT NEEDLE UNASSEMBLED

The Smiths Medical 21-4054-24 Port-A-Cath Kit is a premium implantable vascular access system designed for long-term intravenous therapy. Engineered with a single lumen configuration, this kit features a durable polysulfone and titanium port combined with a high-performance polyurethane catheter measuring 7.8 French in diameter and 76 cm in length. The catheters internal diameter of 1.6 mm and external diameter of 2.6 mm ensure optimal flow rates while maintaining structural integrity during extended use.

This unassembled kit includes a straight, blunt needle designed for safe and efficient access, reducing the risk of accidental needle-stick injuries during handling. The Port-A-Cath system is specifically developed to provide reliable venous access for patients requiring frequent or continuous infusion therapies, including chemotherapy, parenteral nutrition, and long-term medication administration.

With a focus on patient comfort and clinical efficiency, this system is suitable for subcutaneous implantation, offering discreet and secure vascular access while minimizing repeated venipunctures.

Key Benefits

The single lumen design simplifies fluid management while maintaining dependable performance for a wide range of therapies. The combination of polysulfone and titanium enhances durability and biocompatibility, ensuring long-term reliability within the body.

The polyurethane catheter offers excellent flexibility and kink resistance, allowing smooth navigation through the vascular system and reducing the risk of occlusion. Its optimized dimensions support efficient infusion and withdrawal of fluids.

The included blunt needle improves safety during preparation and handling, supporting healthcare professionals in maintaining a safer working environment. The implantable port design significantly improves patient quality of life by reducing the need for repeated needle insertions.

Compatibility and Applications

This Port-A-Cath system is compatible with standard infusion systems and is widely used in oncology, critical care, and long-term treatment settings. It is ideal for administering chemotherapy, antibiotics, blood products, and parenteral nutrition.

The system is suitable for use in hospitals, outpatient clinics, and specialized infusion centers where reliable long-term vascular access is required. It integrates seamlessly into established clinical workflows, supporting both intermittent and continuous infusion protocols.

Usage Guidelines

The device is intended for implantation by trained healthcare professionals under sterile conditions. Proper placement typically involves insertion into a central vein, followed by subcutaneous positioning of the port.

Before use, all components should be inspected for integrity and sterility. The catheter should be flushed according to institutional protocols to ensure patency. During use, aseptic technique must be strictly maintained to reduce the risk of infection.

Routine maintenance includes regular flushing and locking of the catheter, as well as periodic assessment of port function. Any signs of infection, occlusion, or malfunction should be addressed promptly in accordance with clinical guidelines.

Certifications and Safety Standards

The Smiths Medical Port-A-Cath Kit is manufactured in compliance with stringent medical device quality standards. It meets applicable regulatory requirements for safety, performance, and biocompatibility.

Materials used in the construction of the port and catheter are selected for their compatibility with human tissue, reducing the risk of adverse reactions. The device is designed to support safe long-term implantation with minimal complications when used as directed.

Comparison with Competitors

Compared to other implantable port systems, this Smiths Medical kit offers a balanced combination of durability, flexibility, and ease of use. The polysulfone and titanium port construction provides superior strength and resistance to wear compared to plastic-only alternatives.

The polyurethane catheter stands out for its flexibility and resistance to kinking, which enhances patient comfort and reduces maintenance issues. The inclusion of a blunt needle adds an additional layer of safety not always present in competing kits.

Its unassembled configuration allows clinicians greater control during setup and implantation, making it a preferred choice in facilities that prioritize customization and precision.

Typical User Profile and Application Scenarios

This product is commonly used by oncologists, interventional radiologists, and infusion therapy specialists who require dependable long-term venous access solutions for their patients.

Patients undergoing chemotherapy, long-term antibiotic therapy, or nutritional support benefit significantly from the reduced need for repeated venous access. The system is also suitable for individuals with difficult peripheral veins, providing a more consistent and comfortable treatment experience.

Healthcare facilities ranging from large hospitals to specialized treatment centers rely on this device for its reliability and clinical performance.

Best Practices for Use and Maintenance

Proper implantation technique is essential to ensure optimal device performance and longevity. Clinicians should follow established procedural guidelines and manufacturer recommendations during insertion.

Regular flushing protocols should be adhered to in order to maintain catheter patency and prevent clot formation. The use of appropriate locking solutions helps reduce the risk of occlusion.

Routine inspection of the port site for signs of infection or complications is critical. Patients should be educated on how to recognize potential issues and instructed to seek medical attention if concerns arise.

Maintaining strict aseptic technique during access and handling significantly reduces the risk of infection and extends the functional life of the device.

Regulatory and Safety Information

This device is intended for use by qualified healthcare professionals only. It should be used in accordance with all applicable clinical guidelines and institutional protocols.

Potential risks associated with implantable port systems include infection, thrombosis, and catheter-related complications. Proper training, adherence to aseptic technique, and regular monitoring help mitigate these risks.

The product should be stored in a clean, dry environment and used prior to the indicated expiration date. Any compromised or damaged components should not be used.

How to Order

To place an order for the Smiths Medical 21-4054-24 Port-A-Cath Kit, please contact CIA Medicals customer care team. For pricing, availability, and bulk purchase inquiries, call (312) 275-5850. Our team is ready to assist with product selection, shipping options, and any technical questions to ensure you receive the right solution for your clinical needs.

Related Products